123330 — Genic Co Cashflow Statement
0.000.00%
Last trade - 00:00- KR₩23bn
- KR₩29bn
- KR₩28bn
Annual cashflow statement for Genic Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -11,959 | -4,353 | -4,331 | -3,340 | -4,411 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 9,748 | 3,474 | 5,922 | 2,303 | 1,649 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -647 | -1,833 | -580 | -668 | 692 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 1,403 | 313 | 3,324 | 178 | -268 |
| Capital Expenditures | -876 | -776 | -651 | -1,423 | -841 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 1,090 | 155 | 12,790 | -2,467 | 2,612 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 214 | -621 | 12,139 | -3,890 | 1,771 |
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -965 | -3,233 | -3,694 | -10,193 | -3,167 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 585 | -3,620 | 11,750 | -13,839 | -1,681 |